ICP
ABBV icon

Impact Capital Partners’s AbbVie ABBV Stock Holding History

Impact Capital Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.72M Buy
22,723
+463
+2% +$99.6K 1.56% 13
2026
Q1 		$4.84M Sell
22,260
-4,719
-17% -$1.05M 1.46% 14
2025
Q4 		$6.16M Buy
26,979
+568
+2% +$129K 1.83% 8
2025
Q3 		$6.12M Buy
26,411
+1,940
+8% +$395K 1.84% 9
2025
Q2 		$4.54M Buy
24,471
+334
+1% +$62.1K 1.49% 11
2025
Q1 		$5.06M Buy
24,137
+2,231
+10% +$434K 1.83% 7
2024
Q4 		$3.89M Buy
+21,906
New +$4.03M 1.39% 13

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Impact Capital Partners's ABBV Position: Q2 2026 in Review

Impact Capital Partners increased its AbbVie (ABBV) stake by 2.1% in Q2 2026, buying an estimated $99.6K and bringing the position to 22,723 shares worth $5.72M. The position accounts for 1.56% of the portfolio, ranked #13.

Impact Capital Partners first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $6.16M in Q4 2025. 1,094 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Impact Capital Partners held 22,723 shares of AbbVie worth $5.72M as of Q2 2026.
  • Impact Capital Partners bought 463 AbbVie shares in Q2 2026, an estimated $99.6K.
  • AbbVie made up 1.56% of Impact Capital Partners's portfolio in Q2 2026, its #13 holding.
  • Impact Capital Partners first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • Impact Capital Partners's AbbVie position peaked at $6.16M in Q4 2025.
  • 1,094 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Impact Capital Partners's 13F filing for Q2 2026, filed 14 Jul 2026.